Suppr超能文献

[Results of the treatment with biliary dissolvents].

作者信息

Dhumeaux D

机构信息

Service d'hépatologie et de gastro-entérologie, hôpital Henri-Mondor, Créteil.

出版信息

Rev Prat. 1992 Jun 15;42(12):1478-81.

PMID:1411169
Abstract

Cholesterol gallstones can be dissolved by chenodeoxycholic acid or by ursodeoxycholic acid administered orally. This treatment is subject to the following conditions: the gallbladder must be functioning; the gallstones must be radiolucent; the stones must not be too large; the main bile ducts must be patent; the cholelithiasis must be symptomatic but without severe complications. The two biliary acids are equally effective, but ursodeoxycholic acid is preferred to chenodeoxycholic acid because it is devoid of undesirable side-effects. The effectiveness of treatment varies from one published series to the other, but it primarily depends on the size of the gallstones: if they are less than 5 mm wide dissolution can be obtained in 70 to 80% of the cases. After the end of treatment the bile becomes lithogenic again, and a relapse is possible; after 5 years this relapse occurs in about 50% of the patients. The position occupied by biliary acids in the treatment of gallstones is modest, owing to the conditions of their use and to the advantages of surgery, and notably laparoscopic surgery. Biliary acids are usually given to elderly people or to subjects at high risk for anaesthesia or surgery. Attempts have been made to introduce another cholesterol dissolvant, methyl-tert-butyl-ester, directly into the gallbladder by the transcutaneous-transhepatic route. The gallstones were dissolved, but the invasiveness of this technique and the potential toxic effects of this particular drug are such that the indications for this treatment are extremely reduced.

摘要

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验